David I. Quinn
University of Southern California · 820 works · 28,400 citations · h-index 77
Top works
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
- Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
- Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
- International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy
- A Preoperative Nomogram Identifying Decreased Risk of Positive Pelvic Lymph Nodes in Patients With Prostate Cancer
- HER kinase inhibition in patients with HER2- and HER3-mutant cancers
- Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum
- Validation Study of the Accuracy of a Postoperative Nomogram for Recurrence After Radical Prostatectomy for Localized Prostate Cancer
- Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer
- Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
- Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
- Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
- Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
- EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
- Aggressive cutaneous malignancies following cardiothoracic transplantation
- Randomized Controlled Trial of Collaborative Care Management of Depression Among Low-Income Patients With Cancer
- Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
- Frequent loss of estrogen receptor-beta expression in prostate cancer.
- Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial